Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL1V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,727
Award facts
- Contract value 100% obligated
- $44,727.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44.7K delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, awarded on January 21, 2026, was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The contract structure allows Cencora and its subsidiaries to efficiently fulfill government requirements for essential pharmaceutical commodities across multiple therapeutic domains, including diabetes medications such as Ozempic, in support of the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FFL1V?
SPE2DR26FFL1V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FFL1V worth?
The government has obligated $44,727 on SPE2DR26FFL1V.
Is contract SPE2DR26FFL1V an order under another contract?
Yes. SPE2DR26FFL1V is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL1V competed?
The extent of competition for SPE2DR26FFL1V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award